(Q40122497)

English

Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung

scientific article published on January 1, 1980

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

anaplastic carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1007/BF00255273

https://api.crossref.org/works/10.1007/BF00255273

8 September 2023

1 reference

10.1007/BF00255273

https://api.crossref.org/works/10.1007/BF00255273

8 September 2023

author name string

R. E. Taylor

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

I. E. Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

H. T. Ford

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

B. M. Bryant

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

A. J. Casey

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

J. F. Smyth

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6254685

8 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6254685

8 September 2023

publication date

1 January 1980

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00255273.pdf

Portable Document Format

1 reference

10.1007/BF00255273

https://api.crossref.org/works/10.1007/BF00255273

8 September 2023

http://link.springer.com/article/10.1007/BF00255273/fulltext.html

1 reference

10.1007/BF00255273

https://api.crossref.org/works/10.1007/BF00255273

8 September 2023

http://link.springer.com/content/pdf/10.1007/BF00255273

1 reference

10.1007/BF00255273

https://api.crossref.org/works/10.1007/BF00255273

8 September 2023

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

271-273

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monochemotherapy of bronchogenic carcinoma withs special reference to cell type

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cyclophosphamide, adriamycin, intermediate dose methotrexate, and folinic acid rescue (CAMF) in advanced lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: Cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of advanced lung cancer.A randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung: low response rate in a Cooperative Group Study. Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of advanced non-oat cell carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 5-fluorouracil (NSC-19893), adriamycin (NSC-123127), and methotrexate (NSC-740) in lung adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced bronchogenic carcinoma with adriamycin, 5-fluorouracil and methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/6254685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00255273

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40122497&oldid=2203421030"